Which PMS sufferers are most likely to benefit from an SSRI?

October 1997

Which PMS sufferers are most likely to benefit from an SSRI?

Up to 5% of menstruating women have a severe form of PMS called premenstrual dysphoric disorder (PMDD).

These women have both physical and psychological symptoms.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes give insulin to a diabetic who's allergic to latex
Obesity & Weight Loss The withdrawal of Redux (dexfenfluramine) and Pondimin (fenfluramine) leaves lots of unanswered questions
Obesity & Weight Loss Two new drugs for obesity are getting close to approval
Infectious Diseases recent cases of vancomycin-resistant Staph aureus
Women's Health Which PMS sufferers are most likely to benefit from an SSRI?
Women's Health FemPatch, a new Low-dose estrogen patch
Flomax (tamsulosin) for benign prostatic hyperplasia (BPH)
latest thinking is to treat HIV earlier and more aggressively
Patient compliance is EXTREMELY important with this new therapy.
Pediatrics leave their child's antibiotic suspension out of the refrigerator
Practice Transderm Scop, the popular behind-the-ear patch for motion sickness
reduce inappropriate use of antibiotics
combining St. John's wort with other drugs or certain foods
Depression when patients don't respond fully to their antidepressant
Diabetes Beta blockers are very beneficial for diabetics post-MI
Diabetes injecting Humalog AFTER meals